|
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion
|
Dec 2015
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Recent developments in myelodysplastic syndromes
|
Sep 2014
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Origins of myelodysplastic syndromes after aplastic anemia
|
Sep 2017
|
Blood
|
aplastic anemia
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
How I Treat Paroxysmal nocturnal hemoglobinuria
|
Jan 2021
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia
|
Jan 2013
|
Blood
|
aplastic anemia
|
|
Stem and progenitor cell alterations in myelodysplastic syndromes
|
Feb 2017
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children
|
Jan 2013
|
Blood
|
aplastic anemia
|
|
PNH and complement gene variants
|
Apr 2023
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
|
Apr 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|
